27-03-2025
Source: EGX
Company Name : Tenth Of Ramadan Pharmaceutical Industries-Rameda
ISIN Code : EGS381B1C015
Reuters Code : RMDA.CA
Content :
Exchange management decided to resume trading on the companys shares effective 27/03/2025 trading session at 12:35 P.M,
in light of the EGX communication with the company regarding an inquiry about the circulated statement regarding the British company GlaxoSmithKline submitting a voluntary acquisition offer for 33% of the companys shares, a release was received from the company stating that this news has no basis in truth and the company denies issuing any statement in this regard.
EGX30
Advancing : Declining 1.61 : 1
shares
| Sector Name | T/O (EGP Mn) | Mkt % |
| Financial Services & Electronic Payments | 678.71 | 19.72 |
| Real Estate and Hotels | 663.50 | 19.28 |
| Industrial, Construction and Materials | 631.02 | 18.33 |
| Other | 357.68 | 10.39 |
| Food and Beverage | 281.97 | 8.19 |
| Banks | 216.25 | 6.28 |
| Healthcare and Pharmaceuticals | 165.66 | 4.81 |
| Consumer Discretionary | 114.49 | 3.33 |
| Chemicals | 112.64 | 3.27 |
| Transportation, Shipping and Logistics | 108.04 | 3.14 |
| Technology, Media and Telecom | 67.09 | 1.95 |
| Energy | 34.53 | 1.00 |
| Education | 4.76 | 0.14 |